Guangdong Xianqiang Pharmaceutical Co. , Ltd

Guangdong Xianqiang Pharmaceutical Co., Ltd. is a biomedicine high-tech enterprise and a wholly-owned subsidiary of Guangdong Zhongsheng Pharmaceutical Co., Ltd. (stock code: 002317). It is mainly engaged in the research and development, production and sales of chemical drugs. The company was founded in 2002 with a registered capital of 223.9 million yuan. It currently has two subsidiaries: Guangdong Hongqiang Pharmaceutical Sales Co., Ltd. and Shanhaifeng (International) Trading Co., Ltd., one branch company: Guangdong Xianqiang Pharmaceutical Co., Ltd. Zhaoqing Branch office. After nearly two decades of development, the company has gone through a difficult start to entrepreneurship, and has passed the stage of growth and development. With the attention and support of governments at all levels and all walks of life, the company has been rated as a strategic emerging industry cultivation enterprise in Guangdong Province, Guangdong Province Provincial high-growth private enterprises, innovative pilot enterprises in Guangzhou, service-oriented manufacturing enterprise demonstration platform enterprises in the Pearl River Delta region, and Guangzhou tax-paying credit-level A taxpayers. It is a small and medium-sized enterprise mainly supported by the three-level governments of Conghua District, Guangzhou and Guangdong enterprise.